Bain Capital Specialty Finance, Inc. BCSF
We take great care to ensure that the data presented and summarized in this overview for Bain Capital Specialty Finance, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding BCSF
View all-
Bain Capital Credit, LP Boston, MA11.8MShares$179 Million64.54% of portfolio
-
Bank Of America Corp Charlotte, NC4.39MShares$66.6 Million0.0% of portfolio
-
Ubs Group Ag1.45MShares$22 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.33MShares$20.1 Million0.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL1.2MShares$18.2 Million0.09% of portfolio
-
Van Eck Associates Corp1.12MShares$17 Million0.02% of portfolio
-
Melia Wealth LLC Tulsa, OK991KShares$15 Million7.14% of portfolio
-
Starr International CO Inc Zug, V8879KShares$13.3 Million67.65% of portfolio
-
Dimension Capital Management LLC Coral Gables, FL611KShares$9.26 Million1.43% of portfolio
-
Muzinich & Co., Inc. New York, NY554KShares$8.4 Million3.86% of portfolio
Latest Institutional Activity in BCSF
Top Purchases
Top Sells
About BCSF
Bain Capital Specialty Finance, Inc. is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt. It typically invests in companies with EBITDA between $10 million and $150 million.
Insider Transactions at BCSF
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2025
|
Clare Stack Richer Director |
BUY
Open market or private purchase
|
Direct |
1,530
+6.84%
|
$24,480
$16.43 P/Share
|
|
Aug 10
2022
|
Clare Stack Richer Director |
BUY
Open market or private purchase
|
Direct |
3,400
+16.85%
|
$47,600
$14.59 P/Share
|
|
Mar 25
2022
|
Thomas A. Hough Director |
BUY
Open market or private purchase
|
Direct |
6,271
+18.47%
|
$94,065
$15.94 P/Share
|
|
Mar 03
2022
|
Clare Stack Richer Director |
BUY
Open market or private purchase
|
Direct |
3,090
+19.46%
|
$49,440
$16.18 P/Share
|
|
Feb 25
2022
|
Amy Butte Director |
BUY
Open market or private purchase
|
Direct |
1,300
+19.96%
|
$19,500
$15.86 P/Share
|
|
May 11
2021
|
Clare Stack Richer Director |
BUY
Open market or private purchase
|
Direct |
1,563
+14.68%
|
$23,445
$15.9 P/Share
|
|
Dec 03
2020
|
Jeffrey B. Hawkins Director |
BUY
Open market or private purchase
|
Direct |
18,204
+15.4%
|
$218,448
$12.5 P/Share
|
|
Dec 03
2020
|
Michael A Ewald President and CEO |
BUY
Open market or private purchase
|
Direct |
4,000
+5.41%
|
$48,000
$12.52 P/Share
|
Last 12 Months Summary
| Open market or private purchase | 1.53K shares |
|---|